Solriamfetol Shows Therapeutic Benefits on Neuropsychological Outcomes in Excessive Daytime Sleepiness

New research reveals solriamfetol significantly enhances neuropsychological outcomes in patients with obstructive sleep apnea and excessive daytime sleepiness.:

Source: Neurology Read More

Previous PostStudy Highlights High Prevalence and Severity of Restless Legs Syndrome in Pregnant Women
Next PostNegative Study Findings Further Question Effectiveness of Transcranial Direct Stimulation to Treat Insomnia

Solriamfetol Shows Therapeutic Benefits on Neuropsychological Outcomes in Excessive Daytime Sleepiness

Previous PostStudy Highlights High Prevalence and Severity of Restless Legs Syndrome in Pregnant Women

Next PostNegative Study Findings Further Question Effectiveness of Transcranial Direct Stimulation to Treat Insomnia

Related Posts

<![CDATA[Advancing Neuromuscular Research Through Collaboration and Patient-Centered Perspectives: Łukasz Sznajder, PhD, MSc]]>

<![CDATA[GLP-1’s demonstrate neuroprotection in AD, satralizumab Meets Primary Endpoint in Phase 3 Study, Rodolfo Savica, MD, PhD, on Neuroepidemiology and Environmental Exposures in PD]]>

<![CDATA[NeurologyLive® Friday 5 — April 24, 2026]]>

Categories